An influential group that studies the economic burden of medical care has temporarily removed from its website a draft report about the cost-effectiveness of drugs to treat rheumatoid arthritis amid questions about the modeling researchers used in their analysis.
The group initially did little to explain the move, despite having issued a press release for the document last week, replacing the report’s page with a brief statement:
Continue reading Health care group withdraws rheumatoid arthritis drug report